Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: E9B2V7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 39 | 43 | PF00656 | 0.585 |
CLV_C14_Caspase3-7 | 67 | 71 | PF00656 | 0.658 |
CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.625 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.654 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.553 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.654 |
CLV_PCSK_PC1ET2_1 | 150 | 152 | PF00082 | 0.553 |
CLV_PCSK_SKI1_1 | 13 | 17 | PF00082 | 0.696 |
DEG_SPOP_SBC_1 | 80 | 84 | PF00917 | 0.638 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.665 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.658 |
DOC_USP7_UBL2_3 | 146 | 150 | PF12436 | 0.603 |
LIG_14-3-3_CanoR_1 | 96 | 106 | PF00244 | 0.679 |
LIG_APCC_ABBA_1 | 34 | 39 | PF00400 | 0.545 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.655 |
LIG_BRCT_BRCA1_1 | 106 | 110 | PF00533 | 0.639 |
LIG_FHA_2 | 48 | 54 | PF00498 | 0.754 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.693 |
LIG_LIR_Nem_3 | 107 | 113 | PF02991 | 0.619 |
LIG_NRP_CendR_1 | 150 | 153 | PF00754 | 0.666 |
LIG_PCNA_PIPBox_1 | 121 | 130 | PF02747 | 0.483 |
LIG_Pex14_1 | 28 | 32 | PF04695 | 0.565 |
LIG_PTB_Apo_2 | 126 | 133 | PF02174 | 0.487 |
LIG_SH2_NCK_1 | 20 | 24 | PF00017 | 0.639 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.558 |
LIG_WRC_WIRS_1 | 124 | 129 | PF05994 | 0.530 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.727 |
MOD_CK1_1 | 109 | 115 | PF00069 | 0.485 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.595 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.622 |
MOD_CK1_1 | 79 | 85 | PF00069 | 0.595 |
MOD_CK2_1 | 47 | 53 | PF00069 | 0.609 |
MOD_CK2_1 | 61 | 67 | PF00069 | 0.675 |
MOD_GlcNHglycan | 141 | 144 | PF01048 | 0.634 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.596 |
MOD_GlcNHglycan | 78 | 81 | PF01048 | 0.622 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.575 |
MOD_GSK3_1 | 100 | 107 | PF00069 | 0.637 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.518 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.637 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.566 |
MOD_NEK2_1 | 106 | 111 | PF00069 | 0.459 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.520 |
MOD_PIKK_1 | 51 | 57 | PF00454 | 0.656 |
MOD_PKA_2 | 139 | 145 | PF00069 | 0.584 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.708 |
MOD_PKA_2 | 95 | 101 | PF00069 | 0.690 |
MOD_Plk_1 | 57 | 63 | PF00069 | 0.659 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.549 |
MOD_Plk_4 | 57 | 63 | PF00069 | 0.625 |
MOD_SUMO_for_1 | 101 | 104 | PF00179 | 0.601 |
TRG_DiLeu_BaEn_2 | 132 | 138 | PF01217 | 0.510 |
TRG_ER_diArg_1 | 5 | 8 | PF00400 | 0.702 |
TRG_NLS_MonoExtC_3 | 148 | 153 | PF00514 | 0.670 |
TRG_NLS_MonoExtN_4 | 146 | 153 | PF00514 | 0.659 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P974 | Leptomonas seymouri | 47% | 100% |
A0A1X0NT35 | Trypanosomatidae | 32% | 90% |
A0A3S7X5K4 | Leishmania donovani | 90% | 100% |
A0A422NH51 | Trypanosoma rangeli | 32% | 95% |
A4HKG8 | Leishmania braziliensis | 73% | 100% |
A4I7Z5 | Leishmania infantum | 89% | 100% |
D0AA62 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 97% |
Q4Q599 | Leishmania major | 88% | 100% |